| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,241 | 21,006 | 20,917 | 22,529 | | Cost of Revenue | 3,308 | 4,224 | 4,494 | 4,783 | | | Gross Profit |
-
| 16,782 | 16,423 | 17,746 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,812 | 10,145 | 9,623 | 9,510 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,900 | 2,600 | 1,610 | 1,750 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 4,037 | 5,190 | 6,486 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,221 | 4,037 | 5,190 | 6,486 | | Interest Expense | 3,026 | 2,995 | 2,984 | 3,150 | | Income Before Tax | 3,195 | 1,042 | 2,206 | 3,336 | | Income Tax Expense | 992 | 302 | 743 | 1,083 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,203 | 740 | 1,463 | 2,253 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,203 | 740 | 1,463 | 2,253 | | Preferred Stock And Other Adjustments | (1,424) | (437) | (436) | (58) | | | Net Income Applicable To Common Shares | $779 | $303 | $1,027 | $2,195 |
|
0.51% Nasdaq 
Income Statement
